ABSTRACT-Phenylephrine-induced oscillatory contractions in rabbit mesenteric arteries were investi gated in vitro. Adrenergic, cholinergic, or histamine antagonists as well as cyclooxygenase and lipoxygen ase inhibitors had no effect on this phenylephrine-induced oscillation. The removal of extracellular cal cium ions or treatment with a calcium antagonist reduced the amplitude and frequency of the oscilla tion. Removal of the endothelium or treatment with inhibitors of the synthesis or the target enzyme of endothelium-derived relaxing factor (EDRF) also reduced the amplitude and frequency of the oscilla tion. In a perfusion bioassay, the perfusate from an endothelium-intact arterial segment induced oscilla tion of an endothelium-denuded arterial ring recipient. These results suggest that phenylephrine-in duced oscillation is mediated by an endothelium-derived factor such as EDRF and depends on the in flux of extracellular calcium ions.
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Keywords: Phenylephrine-induced oscillation, Endothelium, Mesenteric artery (rabbit), EDRF, Extracellular calcium ion Agonist-induced or spontaneous rhythmic oscillations have been observed in various isolated vessels such as hog carotid artery (1), human coronary artery (2-4), rat mesenteric artery (5), rat aorta (6), dog paw sub cutaneous artery (7), dog renal vein (8) , cat submucosal arteriole (9) , and hypertensive rat femoral artery (10) . In some studies, the oscillations were considered to be myogenic in origin.
Since endothelial cells may release both relaxing fac tors (11) and contracting factors (12) , the contraction or relaxation of vascular smooth muscle induced by some agents has been found to depend on or be modified by these endothelium-derived factors (13, 14) .
There is conflicting evidence regarding the contribu tion of endothelium to the oscillatory responses. The oscillatory responses induced by phenylephrine or pros taglandin F2a in hamster aortas have been shown to de pend on the presence of endothelial cells (15, 16) . In contrast, it has been reported that the oscillations in duced by norepinephrine in tail arteries of spontaneous ly hypertensive rats are not affected by removal of the endothelium (17) .
Although noradrenaline has been shown to evoke oscillatory responses in rabbit mesenteric arteries (18 22) , the exact mechanism involved, including the con tribution of the endothelium to this oscillation, remains unclear. The present study was performed to elucidate the mechanism of phenylephrine-induced oscillation in rabbit mesenteric arteries using organ bath studies and perfusion bioassay. It was found that the oscillation in duced by stimulation with this a 1-agonist depended on the presence of the endothelium and was mediated by endothelium-derived factor.
MATERIALS AND METHODS

Organ bath studies
Male albino rabbits (3.1 3.4 kg) were anesthetized with sodium pentobarbital (20 mg/kg, i.v.) and exsan guinated. The mesenteric artery was immediately re moved from each rabbit, cleaned of adherent connec tive tissue, and cut into approximately 2.5-mm wide rings. In some experiments, the endothelium was re moved by rubbing the intimal surface of the artery with a roughened needle. Each arterial ring was mounted on a specially designed holder and incubated in a 5-ml organ bath containing oxygenated (95% 02, 5% C02) Krebs-Henseleit solution (118 mM NaCI, 4.7 mM KCI, 2.5 mM CaC12, 1.2 mM MgSO4, 1.2 mM KH2PO4, 25 mM NaHCO3, and 10 mM glucose) and maintained at 37°C. The arterial rings were equilibrated for more than 1 hr at a resting tension of 0.6 X g and was washed ev ery 20 min during the equilibration time. Isometric ten sion was recorded with a force-displacement transducer (U-Gage, Shinkoh) connected to a carrier amplifier (AP-601G, Nihon Kohden) and a thermal pen recorder (WS-628G, Nihon Kohden).
After equilibration, the arterial rings were stimulated with phenylephrine (10-5 M). For experiments with antagonists or inhibitors, arterial rings were treated with the agents for 30 min prior to the stimulation, and phenylephrine (105 M) was applied in the presence of these agents. The effect of the absence of extracellular calcium ions was investigated by exposure of the arte rial rings to a calcium-free solution for 10 min.
Perfusion bioassay
An arterial segment with intact endothelium (2-3 cm) was perfused intraluminally with oxygenated Krebs-Henseleit solution (37°C) at a constant flow of 2 ml/min using a roller pump (Harvard, 1210D). The perfusate emerging from the artery was dripped onto an endothelium-denuded arterial ring and the isometric tension was recorded as described above.
In a control experiment, the perfusate from a polyethylene tube, not through an endothelium-intact artery, was dripped onto a test ring.
Data analysis and statistical processing Three parameters, i.e., the tension, amplitude, and frequency of the oscillations, were used to evaluate the effects of phenylephrine. The time course of changes in these parameters was monitored. The minimum point of each oscillatory contraction was measured for the tension. These parameters were expressed as the mean ± S.E.M. Significance of differences was tested using the Dunnett's test.
Drugs
The following drugs were used: L-N-Methyl-mono arginine (L-NMMA), tetrodotoxin, guanethidine, atro pine, indomethacin, diltiazem hydrochloride, cimeti dine, propranolol hydrochloride, diphenhydramine hy drochloride, phenylephrine hydrochloride (Sigma Chemi cal Co., St. Louis, MO, USA), yohimbine hydrochlo ride, methylene blue and quercetin (Nacalai Tesque, Inc., Kyoto, Japan).
Calcium-free solution was prepared by omitting CaC12 from the Krebs-Henseleit solution and adding EGTA to a final concentration of 50,uM.
RESULTS
Characterization of phenylephrine-induced oscillation
Rabbit mesenteric artery with intact endothelium dis played phasic contraction followed by tonic contraction superimposed with rhythmic oscillations when stimu lated with phenylephrine (10-5 M) (Fig. 1) . As the ten sion of the tonic contraction decreased, the amplitude of the oscillations gradually increased and reached a maximum when the tension reached its minimum level. Then the amplitude gradually decreased as the tonic contraction developed. The frequency of the oscillations changed in reverse order to the amplitude. Effects of adrenergic, cholinergic, and histamine antago nists as well as cyclooxygenase and lipoxygenase inhibi tors The effects of adrenergic, cholinergic and histamine antagonists as well as cyclooxygenase and lipoxygenase inhibitors on the response to phenylephrine were ex amined. Yohimbine (10-6 M), propranolol (3 X 106 M), and atropine (10-6 M) were used to block a2 and fl-adrenergic and muscarinic cholinergic receptors, re spectively. Guanethidine (10-6 M) and tetrodotoxin (3 X 10-7 M) were used to inhibit transmitter release from nerve terminals. Diphenhydramine (3 X 10-6 M) and cimetidine (10-5 M) were used to block histamine Hi and H2 receptors, respectively. Indomethacin (10-6 M) and quercetin (10-4 M) were respectively used to inhibit cyclooxygenase and lipoxygenase.
These antagonists or inhibitors had no effect on the oscillation induced by phenylephrine in arterial rings with intact endothelium.
Effect of extracellular calcium
The effects of diltiazem and the removal of ex tracellular calcium ions on the phenylephrine-induced responses of endothelium-intact arterial rings are shown in Fig. 2 Effects of the removal of endothelium, methylene blue and L-NMMA The effects of the removal of the endothelium and the application of methylene blue and L-NMMA on the response to phenylephrine are shown in Fig. 3 . The ac tive tension induced by phenylephrine was potentiated by removal of the endothelium, whereas both the am plitude and the frequency of the oscillations were signi ficantly suppressed.
In arterial rings with intact endothelium, methylene blue increased the resting tension. The phenylephrine induced active tension was also potentiated by treat ment with methylene blue (10-5 M) or L-NMMA (3 X 10-`` M). Methylene blue and L-NMMA both signifi cantly reduced the amplitude and the frequency of the rhythmic oscillations. However, the inhibitory effect of L-NMMA was transient on the amplitude and incom plete on the frequency of the oscillations, respectively.
Perfusion bioassay
The perfusate containing phenylephrine (10-5 M) from an endothelium-intact artery produced contraction and restored oscillations in an endothelium-denuded ring. The perfusate from the polyethylene tube also contracted the de-endothelialized test ring, but failed to induce the oscillation (Fig. 4) . that the release of nerve transmitter or the release of histamine, prostaglandins and/or leukotrienes was in volved in the oscillation. A dependence of the oscillation on extracellular cal cium influx is evident from the inhibitory effect of the absence of extracellular calcium ions and the treatment with diltiazem. The release of endothelium-derived re laxing factor (EDRF) and contracting factor (EDCF) from endothelial cells is known to be calcium depend ent; however, calcium antagonists have been shown not to prevent the release of either EDRF or EDCF (23) . Thus it seems likely that activation of the voltage-de pendent calcium channels of vascular smooth muscle cells may contribute to the oscillatory behaviors. It should be noted that diltiazem failed to inhibit both the phasic and tonic contractions induced by phenylephrine and increased the initial phase of the tonic contraction. The lack of inhibitory effect of diltiazem on both phasic and tonic contraction is consistent with the report that the calcium antagonist nifedipine inhibits the oscillatory response induced by norepinephrine more than it in hibits the phasic and tonic contraction of rabbit mesen teric arteries (20) . Presumably, diltiazem has little effect on the calcium influx promoted by receptor activation at the concentration used in this study. However, we cannot explain why diltiazem increased the initial phase of the tonic contraction.
Methylene blue is known to be a non-specific inhibi tor of soluble guanylate cyclase, the target enzyme of EDRF and nitro compounds (24) , and L-NMMA is an inhibitor of the synthesis of nitric oxide, which has been found to be identical to EDRF (25) . Based on the effects of removal of the endothelium and application of methylene blue or L-NMMA, it appears that the rhythmic oscillation depends on the presence of the en dothelium and possibly an endothelium-derived factor such as EDRF. However, the inhibitory effect of L NMMA on the oscillation was incomplete, even though the concentration of L-NMMA used in this study has been shown to be effective (26) . The reason for this observation is unclear. The finding that the perfusate emerging from the artery with intact endothelium re stored the oscillation in the de-endothelialized arterial ring also suggests that an endothelium-derived factor mediates this rhythmic oscillation. Since EDRF can be released both spontaneously and by some agonists (13) , the increase in phenylephrine-mediated contraction observed in endothelium-denuded rings or rings treated with methylene blue or L-NMMA may be explained by a lack of EDRF release. A rise of the resting tension by methylene blue could be due to inhibition of a back ground production of cGMP (27) .
These rhythmic arterial responses may result from re petitive spikes of intracellular calcium ion concentration in vascular smooth muscle cells. Although the precise mediator or process responsible for the phenylephrine induced tension oscillation could not be determined in the present study, a tempting hypothesis is that an endothelium-derived factor, such as EDRF and/or methylene blue-sensitive nitro compounds, activates the system regulating the intracellular calcium levels (in cluding guanylate cyclase and the voltage-dependent calcium channel) which causes repetitive spikes of the intracellular calcium concentration in smooth muscle cells of rabbit mesenteric arteries.
In conclusion, the phenylephrine-induced oscillation in rabbit mesenteric arteries depends on the influx of extracellular calcium ions, presumably into vascular smooth muscle cells via the voltage-dependent calcium channels, and the presence of intact endothelium. The endothelium-derived factor therefore seems to act as the mediator of this oscillatory response.
